Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peritoneal transport with icodextrin solution.

Olof Heimbürger1

  • 1Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Contributions to Nephrology
|May 25, 2006
PubMed
Summary

Icodextrin, a large molecule used in peritoneal dialysis, offers prolonged ultrafiltration and enhanced solute clearance compared to glucose. The EAPOS study suggests icodextrin may help preserve peritoneal membrane function over time.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2026 ISPD Position Statement on tracking and reporting loss from PD therapy.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

Ultrafiltration and Sodium Removal in Steady Concentration Peritoneal Dialysis: A Prospective, Multicenter, Randomized, Crossover Study.

Journal of the American Society of Nephrology : JASN·2026
Same author

Low Fischer's ratio is associated with increased mortality in patients with kidney failure.

Scientific reports·2026
Same author

Plasma branched-chain amino acids in chronic kidney disease: associations with atherogenic lipids and mortality.

Amino acids·2026
Same author

Pentosidine and Bone Properties in Autosomal Dominant Polycystic Kidney Disease.

Journal of clinical medicine·2025
Same author

Applicability of the Framingham Risk Score in predicting mortality among kidney failure patients: an international analysis.

Clinical kidney journal·2025

Area of Science:

  • Nephrology
  • Biomaterials Science
  • Medical Devices

Background:

  • Icodextrin is a unique large molecular weight osmotic agent in peritoneal dialysis solutions.
  • Unlike glucose, icodextrin's slow absorption due to its size provides prolonged ultrafiltration.
  • It facilitates ultrafiltration via a 'colloid' osmotic mechanism, primarily through small pores.

Purpose of the Study:

  • To evaluate the transport characteristics of icodextrin-based peritoneal dialysis solutions.
  • To compare the effects of icodextrin versus glucose on peritoneal membrane function.
  • To assess the long-term impact of icodextrin on peritoneal transport, referencing EAPOS study findings.

Main Methods:

  • Comparative analysis of peritoneal dialysis solutions containing icodextrin and glucose.

Related Experiment Videos

  • Assessment of ultrafiltration dynamics and solute transport.
  • Review of data from the EAPOS study on peritoneal membrane changes over time.

    • Main Results:

    • Icodextrin solutions exhibit prolonged positive ultrafiltration due to slow absorption.
    • Minimal solute sieving occurs with icodextrin, enhancing convective transport and small solute clearance.
    • Peritoneal membrane transport characteristics are generally similar between icodextrin and glucose solutions.

    Conclusions:

    • Icodextrin provides sustained ultrafiltration and improved solute clearance in peritoneal dialysis.
    • The EAPOS study indicates that icodextrin may mitigate changes in peritoneal transport over time.
    • Icodextrin represents a valuable alternative osmotic agent for peritoneal dialysis patients.